| Trial ID: | L6128 |
| Source ID: | NCT02312375
|
| Associated Drug: |
Fimasartan
|
| Title: |
Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Hypertension
|
| Interventions: |
DRUG: Fimasartan|DRUG: Amlodipine
|
| Outcome Measures: |
Primary: Insulinogenic index, 16 week | Secondary: HOMA β-cell function, 16 week|Insulin resistance, 16 week|Urinary albumin creatinine ratio, urinary protein creatinine ratio, 16 week
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
46
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-03
|
| Completion Date: |
2017-03
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-28
|
| Locations: |
Seoul National University Hospital, Seoul, 110-144, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02312375
|
